VP of Strategic Partnerships, AI Scientist for Pharma

About iollo

iollo was founded by Daniel Gomari (PhD Computational Biology, Stanford) and Prof. Mike Snyder (Stanford Genetics, 900+ publications) after watching pharma companies spend millions and months making R&D decisions that could be computed in days. We built Quinn to fix that. Quinn is an AI scientist that runs autonomous scientific workflows and delivers high-stakes R&D decisions to Fortune 500 pharma companies.

The role

Lead how Quinn enters the pharma R&D market at the executive level.

Pharma R&D leadership makes program-critical decisions every week: which drugs to advance, what to develop next, how to design the next trial. Quinn delivers those decisions in days instead of months, across areas like oncology, immunology, rare disease, and more. Deals are enterprise, multi-stakeholder, and scientifically complex. The opportunity: pharma is a relationship-driven market, and the best partnerships start with executive-level trust built over years.

What you'll do

• Build relationships with pharma R&D leadership
• Navigate multi-stakeholder enterprise procurement alongside our team
• Translate what you learn from partners into product and scientific direction
• Help land enterprise partnerships that require executive-level trust

What you'll need

• 10+ years in pharma or biotech with active, trust-based executive relationships
• Experience bringing new technology or services into pharma R&D workflows
• Scientific literacy to discuss drug development decisions credibly
• A background in life sciences consulting, biotech BD, or pharma-focused SaaS
• Personally generated or influenced $10M+ in enterprise partnerships or revenue

You'll stand out if you

• Are already known and trusted by the people who make program-level R&D decisions
• Have worked across multiple large pharma organizations, not just one

First 90 days

• First 30 days: Active executive conversations with pharma R&D leadership. First qualified partnerships in motion.
• First 60 days: Multiple enterprise deals progressing. You're shaping the strategy, not just executing it.
• First 90 days: Partnerships closed or near-closed. You own the direction.

Why join us

• Quinn is already trusted by Fortune 500 pharma. You accelerate what's working.
• Work directly with the team on the company's most important partnerships.
• Shape how an AI platform enters one of the largest enterprise markets in the world.
• Compensation reflects impact: uncapped success fees mean your earnings grow with what you build.

You'd shape how Quinn reaches pharma R&D. Quinn changes how pharma makes its highest-stakes decisions. You make sure the right people see it. If you've spent your career earning that access, let's talk.